This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The Data
Recovering More High-Quality Cells
WBC Recovery
DCS Processing consistently recovers more WBC than other technologies, featuring an average recovery of ~90% combined with an industry leading low variability (<7%Coefficient of Variation)
Viability
DCS processing maintains cell viability to within 1% of input viability. Viability typically exceeds centrifugal methods.
Superior Removal of Contaminants
RBC Removal
DCS' unique separation mechanism of enables robust removal of RBCs from fresh Leukopacks, leaving essentially RBC free PBMC for next step in the engineering process.
Platelet Removal
DCS platelet removal efficiency is in excess of 99%. This near complete elimination of biological drivers from activated platelets ensures that DCS processed cells are uniquely well positioned for next steps in the manufacturing journey.
Note: All data based on Curate System prototype. (N=54)
DCS™ (Deterministic Cell Separation™ – Curate Microfluidics Platform)